3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
10
Small Cell Lung Carcinoma
9
Mesothelioma, Malignant
7
Carcinoma, Non-Small-Cell Lung
5
Neoplasm Metastasis
4
Sarcoma
3
Thymoma
2
Ovarian Neoplasms
2
Neoplasms
2
Mesothelioma
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Glioma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymic epithelial tumor
1
Stomach Neoplasms
1
Sezary Syndrome
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
sodium thiosulfate
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Platinum
1
Magnetic Resonance Spectroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pelvic Neoplasms
×
Doxorubicin
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled